Related Experiment Video
Updated: Aug 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
The evidence for lipid lowering: type 2 diabetes and coronary heart disease risk
1Wales Heart Research Institute, Bro Morgannwg NHS Trust, Bridgend. Delyth.Townsend@bromor-tr.wales.nhs.uk
Abstract:
Recent research suggests the risk of heart disease in patients with or without diabetes can be cut dramatically by prescribing cholesterol-lowering drugs more aggressively. But is there enough evidence yet to justify changed practice? While nurses need to keep up with these developments, their educating and supporting role is still vital.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Type II Diabetes I: Introduction
Lipids: Dietary Sources and Requirements